Cord Blood

For both therapeutic and financial reasons, the cord blood industry has been witnessing record levels of M&A activity in recent years, with market leaders gaining market share at the expense of smaller competitors and investors vying for buy-in opportunities. Novel pricing strategies, product cross-sells and upsells, and ingenious online and offline marketing strategies are being implemented by the industry’s market leaders. Meanwhile, new technologies to support ex vivo cord blood expansion are advancing at brisk pace, indicating a promising future for the industry.

Given the operational efficiencies associated with market consolidation, the global cord blood and tissue banking market is being consolidated by a handful of large and well capitalized market competitors. [Read more…]

The idea of cultured meat is not new and it has long been around, although there have not been the techniques to produce it until recently. Cultured meat was seemingly first mentioned in 1897 within a science fiction novel titled Auf Zwei Planeten, and further mentioned within a number of other novels throughout the 19^th century.

[Read more…]

Did you know that more than 70% of the global cord blood market is controlled by the world’s 15 largest cord blood banking operators? It’s an incredible figure, but true.

The reason for this is that massive cord blood industry consolidation has happened in recent years, particularly within the U.S, Europe, Asia, and Latin America, with: [Read more…]